<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01491763</url>
  </required_header>
  <id_info>
    <org_study_id>LAL Ph-2008</org_study_id>
    <nct_id>NCT01491763</nct_id>
  </id_info>
  <brief_title>Chemotherapy and Imatinib in Young Adults With Acute Lymphoblastic Leukemia Ph (BCR-ABL) POSITIVE</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>PETHEMA Foundation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>PETHEMA Foundation</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      20-25% of patients over 15 years with acute lymphoblastic leukemia (ALL) have the
      Philadelphia chromosome or BCR-ABL rearrangement. Traditionally, intensive chemotherapy
      followed by hematopoietic stem cell transplantation (HSCT) have formed the basis allogeneic
      treatment of this disease, but the results have been poor (60-75% complete remissions-RC-and
      probability of long-term survival less than 20%). The effectiveness of imatinib for
      hematologic responses in patients with Ph + (observed in phase I and II) led to its use in
      phase III trials in combination with chemotherapy. They saw a chance of obtaining the RC
      above 90%, with acceptable toxicity, a molecular response rate (MR) of 40-50%, and prolonged
      follow-up studies, a probability of disease-free survival (DFS ) of 30-50%, significantly
      higher than historical controls with the same chemotherapy without imatinib. This led to the
      approval of imatinib by the rating agencies in the U.S., Europe and Japan as a treatment for
      Ph + in combination with chemotherapy.

      Of the studies that led to the approval of this indication for imatinib, and other incurred
      after, the following conclusions can be drawn:

      There is no specific pattern of combination of imatinib (at doses of 600 mg / day, po) and
      chemotherapy. However, when compared with concomitant alternating with the first achieved a
      higher rate of RM at the end of induction, although this did not influence DFS.

      In studies in elderly patients has achieved a high CR rate (almost 100% in all series), only
      imatinib and glucocorticoids, suggesting that an attenuated induction may be sufficient to
      achieve CR in young patients with minimal toxicity, which further compromises the
      administration of treatment and allow for an allogeneic HSCT with minimal toxic load
      possible.

      Although there is no consensus on the indication of allogeneic HSCT in first CR when given
      imatinib associated with intensive chemotherapy is an option that is done in most studies.

      The allogeneic HSCT is most effective when carried out in complete molecular response to or
      greater than when there is more residual disease. However, the impact of MRI to obtain early
      (after induction) on survival is not clear. So far-reaching goal is to make the TPH in
      complete molecular response situation or greater.

      The relapse of the disease at the molecular level is still short-term (less than 3 months) of
      hematological relapse. This implies the need for frequent monitoring of residual disease (ER)
      The frequency of relapse post HSCT is high (around 30%), raising the need for any post HSCT
      treatment, including imatinib included. Are currently ongoing clinical trials comparing the
      systematic administration of imatinib after administration TPH face is detected only when ER.

      The applicability of the administration of imatinib after HSCT is limited by toxicity related
      to the procedure of TPH, is making frequent dose reduction or discontinuation.

      Therefore, a reasonable approximation treatment of Ph + outside the context of a clinical
      trial is to get as many molecular responses before allogeneic HSCT in a position to make the
      same MRI complete or greater. After TPH, must be very close monitoring of the ER, and
      imatinib is administered as soon as you notice the loss of molecular response.

      In patients who can not make an allogeneic HSCT for lack of histocompatible donor or
      contraindications for its realization it is recommended imatinib and chemotherapy, although
      there are studies that have undergone an autologous HSCT, followed or not treatment
      &quot;maintenance&quot; with imatinib. The low toxicity of autologous HSCT and no effect of graft
      versus leukemia are strongly recommended the administration of maintenance therapy with
      imatinib combined with chemotherapy or not.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Induction Chemotherapy

        -  Vincristine (VCR): 1.5 mg/m2 (maximum dose 2 mg) iv days 1, 8, 15 and 22

        -  daunorubicin (DNR) 45 mg/m2 i.v. days 1, 8, 15 and 22

        -  Prednisone (PDN): 60 mg/m2 per day, i.v. or p.o., days 1-27

        -  Imatinib 600 mg p.o. from day 1 until the beginning of the consolidation. Important
           Note: The administration of imatinib be initiated as soon as the outcome of cytogenetic
           and molecular study, which will be known under normal conditions during prophase
           consolidation

      Patients should be in RC and shall be a minimum of 2 weeks of finding it. Patients did not
      discontinue treatment with imatinib during this period. Minimum counts to start the
      consolidation are: neutrophils&gt; 1x109 / L and platelets&gt; 100x109 / L.

        -  Mercaptopurine (MP) 50 mg/m2, p.o. days 1 to 7, 28 to 35 and 56 to 63

        -  MTX: 1.5 g/m2, i.v. continuous infusion for 24 hours on days 1, 28 and 56.

        -  VP-16: 100 mg/m2 every 12 hours, i.v. (1 hour infusion) on days 14 and 42

        -  ARA-C: 1000 mg/m2 every 12 hours, i.v. (3-hour infusion) days 14-15 and 42-43

        -  triple intrathecal treatment days 1, 28 and 56

        -  Imatinib 600 mg / d po, from day 1 to 15 days before the TPH.

      During consolidation therapy is recommended in primary prophylaxis with G-CSF or found
      neutropenia (&lt;0.5 x109 / L). This factor was administered daily until the neutrophil count is
      &gt; 1x109 / L in two consecutive measurements. Alternatively, PEG-filgrastim can be used (eg 16
      and 44), at the discretion of each center

      Allogenic THP or Autologous TPH
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 2008</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy in terms of number of complete response</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Acute Lymphoblastic Leukemia Ph Positive</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Imatinib</intervention_name>
    <description>600 mg p.o. from day 1 until consolidation</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with Ph (BCR/ABL) positive de novo &lt; 55 years old (it is advisable to include
             patients over 55 years LAL07OPH protocol).

          -  Performance status 0-2 (Appendix B) may include patients with performance status &gt; 2
             attributable to LAL.

          -  Patients without functional impairment of organs: liver function: total bilirubin,
             AST, ALT, alfa-GT and alkaline phosphatase less than 3 times the upper limit of normal
             laboratory renal function: serum creatinine &lt; 2 mg/dL or clearance creatinine &gt; 30
             ml/min (except renal function attributable to LAL) cardiac function (Appendix B)
             normal: ventricular EF &gt; 50%, absence of severe chronic respiratory disease. In the
             event that alterations are secondary to the disease is at the discretion of the
             investigator to determine if the patient can be included in the trial.

        Exclusion Criteria:

          -  Any other variety of LAL

          -  Patients with a history of coronary artery disease, valvular or hypertensive heart
             disease

          -  Patients with chronic liver disease

          -  Patients with chronic respiratory failure

          -  Renal failure not due to LAL

          -  Patients with positive HIV status

          -  No serious neurological abnormalities due to LAL

          -  Impact on overall severe (grade 3 or 4 of the WHO scale) not attributable to the LAL

          -  Pregnant or breastfeeding

          -  initial blast crisis CML
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Josep MÂª Ribera, Dr</last_name>
    <phone>34 93 497 89 74</phone>
    <email>jribera@iconcologia.net</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital Central de Asturias</name>
      <address>
        <city>Oviedo</city>
        <state>Asturias</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carrera Dolores, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Carrera Dolores, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>H. Son Llatzer</name>
      <address>
        <city>Palma de Mallorca</city>
        <state>Baleares</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Bargay Lleoneart Joan, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Germans Trias i Pujol and all Hospital Pethema</name>
      <address>
        <city>Badalona</city>
        <state>Barcelona</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jose MÂª Ribera, Dr</last_name>
      <email>jribera@iconcologia.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital de MatarÃ³</name>
      <address>
        <city>MatarÃ³</city>
        <state>Barcelona</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bosch LLobet, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Bosch Alba, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Canarias</name>
      <address>
        <city>Tenerife</city>
        <state>Canarias</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>GonzÃ¡lez Brito Gloria, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Gonzalez brito Gloria, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital general de CastellÃ³n</name>
      <address>
        <city>Castello</city>
        <state>CastellÃ³n</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>GarcÃ­a Raimundo, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Garcia Raimundo, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Complejo Hospitalario Universitario de Santiago</name>
      <address>
        <city>Santiago de Compostela</city>
        <state>La CoruÃ±a</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bello JosÃ© Luis, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Bello JosÃ© Luis, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ClÃ­nica Universitaria de Navarra</name>
      <address>
        <city>Pamplona</city>
        <state>Navarra</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Prosper Felipe, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Prosper Felipe, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital de Navarra</name>
      <address>
        <city>Pamplona</city>
        <state>Navarra</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Perez Equiza EncarnaciÃ³n, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Perez Equiza EncarnaciÃ³n, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital General de Albacete</name>
      <address>
        <city>Albacete</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital de AlcorcÃ³n</name>
      <address>
        <city>AlcorcÃ³n</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>PeÃ±alver Francisco, Dr</last_name>
    </contact>
    <investigator>
      <last_name>PeÃ±alver Francisco, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital General de Alicante.</name>
      <address>
        <city>Alicante</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rivas Concha, Dra</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital de CabueÃ±es</name>
      <address>
        <city>Asturias</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital de Badalona Germans Trias i Pujol</name>
      <address>
        <city>Badalona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Oriol Albert, DR</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clinic y Provincial de Barcelona</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Esteve Jordi, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Esteve Jordi, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital ClÃ­nico y Provincial de Barcelona</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rovira Montse, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Rovira Montse, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital de la Santa Creu i Sant Pau.</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sierra Jordi, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital de la Santa Creu i Sant Pau.</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jordi Sierra, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital de la Santa Creu i Sant Pau</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sureda Anna, Dr</last_name>
      <email>asureda@hsp.santpau.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital de la santa Creu i Sant Pau</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Delgado Julio, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Delgado Julio, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital del Mar</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Abella Eugenia, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital del Mar</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Salar Antonio, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Salar Antonio, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital del Mar</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Besses Carles, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Besses Carles, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Duran i Reynals - ICO L'Hospitalet</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dr. Rafael Duarte Palomino, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Basurtuko Ospitalea</name>
      <address>
        <city>Basurto</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Beltran de Heredia JosÃ© MÂª, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Beltran de Heredia Jose MÂª, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Complejo Hospitalario de CÃ¡ceres</name>
      <address>
        <city>CÃ¡ceres</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bergua Juan Miguel, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Bergua Juan Miguel, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Complejo Hospitalario Reina SofÃ­a</name>
      <address>
        <city>CÃ³rdoba</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Torres Antonio, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Torres Antonio, DR</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Area Hospitalaria Juan RamÃ³n Jimenez</name>
      <address>
        <city>Huelva</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>FernÃ¡ndez Antonio, Dr</last_name>
    </contact>
    <investigator>
      <last_name>FernÃ¡ndez Antonio, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Juan RamÃ³n JimÃ©nez</name>
      <address>
        <city>Huelva</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>FernÃ¡ndez Antonio, Dr</last_name>
    </contact>
    <investigator>
      <last_name>FernÃ¡ndez Antonio, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital del SAS de Jerez de la Frontera</name>
      <address>
        <city>Jerez de la Frontera</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angel LeÃ³n, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital general de Jerez de la Frontera</name>
      <address>
        <city>Jerez de la Frontera</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>LeÃ³n Angel, Dr</last_name>
    </contact>
    <investigator>
      <last_name>LeÃ³n Angel, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Arnau de Vilanova</name>
      <address>
        <city>Lleida</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sanchez Juan Manuel, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Sanchez Juan Manuel, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Complexo Hospitalario Xeral-Calde</name>
      <address>
        <city>Lugo</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Arias JesÃºs, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ClÃ­nica La ConcepciÃ³n</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>RomÃ¡n Alejandro, Dr</last_name>
    </contact>
    <investigator>
      <last_name>RomÃ¡n Alejandro, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ClÃ­nica Puerta de Hierro</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>NicolÃ¡s Manuel, Dr</last_name>
    </contact>
    <investigator>
      <last_name>NicolÃ¡s Manuel, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital 12 de Octubre. Madrid</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lahuerta juan JosÃ©, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Lahuerta Juan JosÃ©, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clinico San Carlos</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>MartÃ­nez Rafael, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Martinez Rafael, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital ClÃ­nico San Carlos de Madrid</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Del Potro Eloy, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Del Potro Eloy, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital ClÃ­nico San Carlos de Madrid</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Diaz Mediavilla Joaquin, Dr</last_name>
    </contact>
    <investigator>
      <last_name>DÃ­az Mediavilla JoaquÃ­n, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital de Fuenlabrada</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Bravo Barahona Pilar, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital de la Princesa</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>AdriÃ¡n Alegre, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Alegre AdriÃ¡n, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital de Madrid, S.A.- Norte Hospital General</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>PÃ©rez de Oteyza Jaime, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Gregorio MaraÃ±Ã³n</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pintado TomÃ¡s, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Pintado TomÃ¡s, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital RamÃ³n y Cajal</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Blanchard MÂª JesÃºs, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Blanchard MÂª JesÃºs, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de la Princesa</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>De la CÃ¡mara Rafael, Dr</last_name>
    </contact>
    <investigator>
      <last_name>de la CÃ¡mara Rafael, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Princcipe de Asturias</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Burgaleta Carmen, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Althaia, Xarxa Asistencial de Manresa</name>
      <address>
        <city>Manresa</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Subira Maricel, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital General Univeristario Morales Messeguer</name>
      <address>
        <city>Murcia</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Felipe de Arriba, Dr</last_name>
    </contact>
    <investigator>
      <last_name>de Arriba Felipe, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Sta. Maria del Rosell</name>
      <address>
        <city>Murcia</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>IbaÃ±ez JerÃ³nima, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>. Hospital ClÃ­nico Universitario Virgen de la Victoria</name>
      <address>
        <city>MÃ¡laga</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Moreno MÂª JosÃ©, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>. Hospital ClÃ­nico Universitario Virgen de la Victoria</name>
      <address>
        <city>MÃ¡laga</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gema Ramirez</last_name>
    </contact>
    <investigator>
      <last_name>Ramirez Gema, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Carlos Haya</name>
      <address>
        <city>MÃ¡laga</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cuesta Angeles, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Cuesta Angeles, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Carlos Haya</name>
      <address>
        <city>MÃ¡laga</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bethancourt ConcepciÃ³n, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Bethancourt ConcepciÃ³n, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Carlos Haya</name>
      <address>
        <city>MÃ¡laga</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Barrios Manuel, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Barrios Manuel, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital de MÃ©rida</name>
      <address>
        <city>MÃ©rida</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Lopez Carlos, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital del RÃ­o CarriÃ³n</name>
      <address>
        <city>Palencia</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ortega Frenando, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Ortega Fernando, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital de Gran Canaria Doctor NegrÃ­n</name>
      <address>
        <city>Palma De Gran Canaria</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Suarez Alexia, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ClÃ­nica Universitaria de Navarra</name>
      <address>
        <city>Pamplona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Javier PÃ©rez Calvo, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Javier PÃ©rez Calvo, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital de Montecelo</name>
      <address>
        <city>Pontevedra</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Allegue MÂª Jose, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CorporaciÃ³ Sanitaria Parc TaulÃ­</name>
      <address>
        <city>Sabadell</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>RÃ¡mila Elena, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital ClÃ­nico de Salamanca</name>
      <address>
        <city>Salamanca</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>San Miguel JesÃºs, Dr</last_name>
    </contact>
    <contact_backup>
      <last_name>Mateos Maria Victoria, Dr</last_name>
    </contact_backup>
    <investigator>
      <last_name>San Miguel Izquierdo JesÃºs, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital ClÃ­nico Universitario de Salamanca</name>
      <address>
        <city>Salamanca</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>HernÃ¡ndez Rivas JosÃ© MÂª, Dr</last_name>
    </contact>
    <investigator>
      <last_name>HernÃ¡ndez Rivas JosÃ© MÂª, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital ClÃ­nico Universitario</name>
      <address>
        <city>Salamanca</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>MÂª Consuelo del CaÃ±izo, Dr</last_name>
    </contact>
    <investigator>
      <last_name>MÂª Consuelo del CaÃ±izo, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital de Donostia</name>
      <address>
        <city>San SebastiÃ¡n</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>MarÃ­n JuliÃ¡n, Dr</last_name>
    </contact>
    <investigator>
      <last_name>MarÃ­n JuliÃ¡n, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hoaspital MarquÃ©s de Valdecilla</name>
      <address>
        <city>Santander</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Conde Eulogio, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Conde Eulogio, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital General de Segovia</name>
      <address>
        <city>Segovia</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hernandez JosÃ©, Dr</last_name>
    </contact>
    <investigator>
      <last_name>HernÃ¡ndez JosÃ©, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Complejo Hospitalario Regional Virgen del RocÃ­o</name>
      <address>
        <city>Sevilla</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>MartÃ­n SÃ¡nchez JesÃºs, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Martin Sanchez JesÃºs, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Joan XIII de</name>
      <address>
        <city>Tarragona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Natalia Rodriguez, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Natalia Rodriguez, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Joan XXIII</name>
      <address>
        <city>Tarragona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Escoda Lourdes, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Escoda Lourdes</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital ClÃ­nico de Valencia.</name>
      <address>
        <city>Valencia</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tormo Mar, Dra</last_name>
    </contact>
    <investigator>
      <last_name>Teruel CasasÃºs Ana Isabel, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital ClÃ­nico Universitario de Valencia</name>
      <address>
        <city>Valencia</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Solano Carlos, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Solano Carlos, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital ClÃ­nico Universitario</name>
      <address>
        <city>Valencia</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>HernÃ¡ndez Juan Carlos, Dr</last_name>
    </contact>
    <investigator>
      <last_name>HernÃ¡ndez Juan Carlos, DR</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital ClÃ­nic</name>
      <address>
        <city>Valencia</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Terol Maria JosÃ©, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Terol MÂª JosÃ©, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Dr Pesset</name>
      <address>
        <city>Valencia</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ferrer Secundino, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Ferrer Secundino, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital La Fe</name>
      <address>
        <city>Valencia</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>De la Rubia Javier, Dr</last_name>
      <email>delarubia_jav@gva.es</email>
    </contact>
    <investigator>
      <last_name>De la Rubia Javier, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Dr. Peset</name>
      <address>
        <city>Valencia</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rafecas Javier, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Rafecas Javier, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital ClÃ­nico de Valladolid</name>
      <address>
        <city>Valladolid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Fernandez Calvo Francisco, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Complejo Hospitalario Xeral-Cies</name>
      <address>
        <city>Vigo</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>PoderÃ³s ConcepciÃ³n, Dr</last_name>
    </contact>
    <investigator>
      <last_name>PoderÃ³s ConcepciÃ³n, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital do Meixoeiro</name>
      <address>
        <city>Vigo</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Txagorritxu</name>
      <address>
        <city>Vitoria</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guinea Josep MÂª, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Guinea JosÃ© MÂª, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital ClÃ­nico Lozano Blesa</name>
      <address>
        <city>Zaragoza</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>OlivÃ© Maite, Dr</last_name>
    </contact>
    <investigator>
      <last_name>OlivÃ© Maite, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 12, 2011</study_first_submitted>
  <study_first_submitted_qc>December 13, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 14, 2011</study_first_posted>
  <last_update_submitted>March 19, 2018</last_update_submitted>
  <last_update_submitted_qc>March 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 20, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Leukemia</mesh_term>
    <mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
    <mesh_term>Leukemia, Lymphoid</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Imatinib Mesylate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

